
Europe’s moment to lead: Backing research in a global race
European leaders have launched a campaign to secure the continent's future by prioritizing health research and innovation as a strategic economic driver.
Europe faces a dual challenge: an aging population with rising chronic disease rates and new security threats from biosecurity, artificial intelligence, climate change, and drug-resistant bacteria. The European Union is responding by framing health research not as a discretionary cost but as a pillar of future economic growth.
The campaign argues that European teachers, biologists, nurses, and manufacturers have already developed innovations that protect populations. It asserts that backing health research is the right choice to enable Europe to lead and support sustainable growth within a new global health architecture.
Return on investment
Proponents point to concrete examples of how health research yields unexpected returns. A tuberculosis vaccine has served as a frontline treatment for bladder cancer for over 40 years, while technology first developed for a malaria vaccine now protects millions against shingles. mRNA research enabled Europe's fastest-ever vaccine response to Covid-19.
The initiative claims that these achievements demonstrate the value of public investment. It suggests that public budget pressure can act as a catalyst, focusing priorities and turning constraints into innovative breakthroughs. The goal is to maximize the impact of European money by working and funding a shared agenda together, rather than as disjointed nations.
By building on its strengths in life sciences, Europe aims to advance its health sovereignty and seize opportunities in scientific discovery, next-generation vaccines, and biomanufacturing. The strategy posits that basic and applied research will generate new technologies, intellectual property, skilled jobs, and revenues that protect European health, growth, and wealth.
Strategic imperative
The campaign concludes that Europe's health, security, and prosperity depend on its ability to contribute to and benefit from global networks of research and innovation. It warns that retreating from global research would not reduce vulnerability but would increase it. Investing and engaging beyond borders is framed as a strategic imperative for the continent.
The initiative calls on the public to sign a declaration supporting the concept of a 'Health Dividend.' This dividend is defined as the collective returns from health research that strengthen Europe's future while delivering benefits today.